IgniteIt · Cannabis Capital ConferenceMIAMI 2027March 24–26 · The Diplomat Beach Resort, Hollywood FL
Home ⟩ Insights
Insights
fda
3 min read • April 12, 2024
FDA Commissioner To House Committee: ‘There’s No Reason For DEA To Delay’ Cannabis Rescheduling
1 min read • April 11, 2024
‘FDA Head Says There’s ‘No Reason For DEA To Delay’ Rescheduling Marijuana’ – Marijuana Moment
2 min read • February 29, 2024
Kratom, CBD, Marijuana: Regulatory Update, Get Tuned In Under 2 Minutes
4 min read • February 12, 2024
‘FDA Grants Priority Review Of MDMA-Assisted Therapy For PTSD, Psychedelics Drug Development Company Says’ – Marijuana Moment
4 min read • April 12, 2023
EXCLUSIVE: Descheduling/Rescheduling Cannabis: Will It Be An Expeditious Path To 280E Relief? ‘This Is The One Moment To Do It’
3 min read • March 30, 2023
FDA’s Scarce CBD Regulations, MO Weed Measures, Cannabis In NJ, Kratom’s Legal Statues & More
2 min read • February 27, 2023
SciSparc Signs Agreement For The Supply Of CBD-Rich Cannabis Oil For Its Clinical Trial On Children With Autism Spectrum Disorder
2 min read • February 15, 2023
Medical Cannabis For Autism: Zelira Receives $8.6M For FDA Clinical Trials For Treatment
3 min read • January 26, 2023
FDA Says No To CBD Marketing As Food Or Dietary Supplement, Expert Warns Decision Could Effect Cannabis Legislation
1 min read • January 26, 2023
FDA Denying 3 Citizen Petitions That Asked Agency To Conduct Rulemaking To Allow Marketing Of CBD Products As Dietary Supplements
1 min read • January 26, 2023
FDA Concluded New Regulatory Pathway For CBD Is Needed That Balances Individuals’ Desire For Access To CBD Products; FDA Convened High-Level Internal Working Group To Explore Potential Regulatory Pathways For CBD Products
3 min read • January 4, 2023
Vaping Nicotine Most Common Substance Use Among Teens, Surpassing Cannabis & Booze
Latest Headlines
View All
3 min read • October 16, 2026
Inside Cronos’ 58% Revenue Growth: Market Share and Expansion
3 min read • October 15, 2026
DEA Cannabis Rescheduling Faces New October 21 Deadline After Judge Weighs Reopening Hearing
2 min read • October 15, 2026
Glass House Eyes European Cannabis Exports After GACP Certification
2 min read • October 15, 2026
“Curaleaf’s Revised Offer Still Does Not Reflect the Value”: Aurora Rejects $5 Hostile Bid
6 min read • October 15, 2026
Organigram Wants More Than Revenue From Germany. It Wants the Whole Margin
5 min read • October 14, 2026
The Real Cost of a Cannabis Gummy: Azuca’s CEO on Manufacturing Margins and Scale
5 min read • October 14, 2026
Cannabis Products Have to Earn Their Shelf Space. Curio Wellness Explains How
min read • October 13, 2026
Cronos Has a $1 Billion War Chest. Zuanic Sees Up to 3x Upside
5 min read • October 13, 2026
Marijuana Rescheduling Hits a New Deadline Today, With Court Fight Stretching Into 2027
4 min read • October 9, 2026
Vireo Secures $60 Million at 8.5% to Refinance Cannabis Facilities in New York and Florida
6 min read • October 9, 2026
“This Defies All Fiduciary Logic”: Curaleaf Fires Back at Aurora; Rival Deal Rumors Swirl
4 min read • October 9, 2026
Aurora Doubles German Cannabis Output, Giving Investors More to Weigh in Curaleaf Takeover
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Andy Barr
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
california cannabis
Cannabis
cannabis clubs
cannabis cultivation
cannabis earnings
cannabis farms
cannabis study
CBD
Christopher Dillis
CNBC
Commodities
Congress cannabis
Congress hemp
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
first quarter earnings
Forex
Futures
Gaming
General
germany cannabis
Global
Government
Guidance
Health Care
Hedge Funds
hemp bill
hemp legalization
hemp regulation
hemp rules
Hot
IgniteIt Events
illegal cannabis farms
Initiation
Insider Trades
Insurance
Interview
intoxicating hemp-derived products
Intraday Update
IPOs
James Comer
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Rescheduling
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
THC
Top Stories
Topics
Trading Ideas
Travel
UC Berkeley Cannabis Research Center
unlicensed cannabis
Upgrades
WIIM
WNBA
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.